{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:10:38Z","timestamp":1760026238616},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T00:00:00Z","timestamp":1538092800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Urol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1038\/s41585-018-0102-1","type":"journal-article","created":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T08:59:54Z","timestamp":1538125194000},"page":"717-718","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Mitomycin C in the treatment of anterior urethral strictures"],"prefix":"10.1038","volume":"15","author":[{"given":"Joon J.","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tricia L.","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher R.","family":"Chapple","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,28]]},"reference":[{"key":"102_CR1","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/S0022-5347(01)62894-5","volume":"160","author":"CF Heyns","year":"1998","unstructured":"Heyns, C. F. et al. Treatment of male urethral strictures: is repeated dilation or internal urethrotomy useful? J. Urol. 160, 356\u2013358 (1998).","journal-title":"J. Urol."},{"key":"102_CR2","doi-asserted-by":"publisher","first-page":"857","DOI":"10.2147\/OPTH.S48745","volume":"2","author":"T Bergen Van","year":"2014","unstructured":"Van Bergen, T. et al. Improving patient outcomes following glaucoma surgery: state of the art and future perspectives. Clin. Ophthalmol. 2, 857\u2013867 (2014).","journal-title":"Clin. Ophthalmol."},{"key":"102_CR3","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1111\/j.1442-2042.2004.00959.x","volume":"11","author":"A Ayyildiz","year":"2004","unstructured":"Ayyildiz, A. et al. Effect of intraurethral mitomycin-C on healing and fibrosis in rats with experimentally induced urethral stricture. Int. J. Urol. 11, 1122\u20131126 (2004).","journal-title":"Int. J. Urol."},{"key":"102_CR4","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.eururo.2006.11.038","volume":"51","author":"H Mazdak","year":"2007","unstructured":"Mazdak, H., Meshki, I. & Ghassami, F. Effect of mitomycin C on anterior urethral stricture recurrence after internal urethrotomy. Eur. Urol. 51, 1089\u20131092 (2007).","journal-title":"Eur. Urol."},{"key":"102_CR5","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1046\/j.1464-410x.1999.00111.x","volume":"83","author":"A Yakubu","year":"1999","unstructured":"Yakubu, A. et al. Extensive urethral stricture after using mitomycin in local anaesthetic jelly for urethral tumours. BJU Int. 83, 873\u2013874 (1999).","journal-title":"BJU Int."},{"key":"102_CR6","doi-asserted-by":"publisher","first-page":"192710","DOI":"10.1155\/2014\/192710","volume":"2014","author":"S Kumar","year":"2014","unstructured":"Kumar, S. et al. Efficacy of optical internal urethrotomy and intralesional injection of vatsala-santosh PGI tri-inject (triamcinolone, mitomycin C, and hyaluronidase) in the treatment of anterior urethral stricture. Adv. Urol. 2014, 192710 (2014).","journal-title":"Adv. Urol."},{"key":"102_CR7","doi-asserted-by":"publisher","first-page":"650","DOI":"10.4111\/kju.2015.56.9.650","volume":"56","author":"L Ali","year":"2015","unstructured":"Ali, L. et al. Efficacy of mitomycin C in reducing recurrence of anterior urethral stricture after internal optical urethrotomy. Kor. J. Urol. 56, 650\u2013655 (2015).","journal-title":"Kor. J. Urol."},{"key":"102_CR8","first-page":"75","volume":"8","author":"M Moradi","year":"2016","unstructured":"Moradi, M. et al. Safety and efficacy of intraurethral mitomycin C hydrogel for prevention of post-traumatic anterior urethral stricture recurrence after internal urethrotomy. J. Inj. Violence Res. 8, 75\u201379 (2016).","journal-title":"J. Inj. Violence Res."},{"key":"102_CR9","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.urology.2017.07.017","volume":"110","author":"MR Farrell","year":"2017","unstructured":"Farrell, M. R., Lawrenz, C. W. & Levine, L. A. Internal urethrotomy with intralesional mitomycin C: an effective option for endoscopic management of recurrent bulbar and bulbomembranous urethral strictures. Urology 110, 223\u2013227 (2017).","journal-title":"Urology"},{"key":"102_CR10","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.juro.2014.08.104","volume":"193","author":"JD Redshaw","year":"2015","unstructured":"Redshaw, J. D. et al. Intralesional injection of mitomycin C at transurethral incision of bladder neck contracture may offer limited benefit: TURNS Study Group. J. Urol. 193, 587\u2013592 (2015).","journal-title":"J. Urol."}],"container-title":["Nature Reviews Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41585-018-0102-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41585-018-0102-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41585-018-0102-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T22:24:26Z","timestamp":1684621466000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41585-018-0102-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,28]]},"references-count":10,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["102"],"URL":"https:\/\/doi.org\/10.1038\/s41585-018-0102-1","relation":{},"ISSN":["1759-4812","1759-4820"],"issn-type":[{"value":"1759-4812","type":"print"},{"value":"1759-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,28]]},"assertion":[{"value":"28 September 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.R.C. has been a consultant, adviser, grant recipient, researcher, author, speaker, meeting participant, and\/or been involved in studies or trials for Astellas Pharma, Bayer Schering Parma AG, Galvani Bioelectronics (GSK), Ipsen, Lupin Limited, Pfizer, Pierre Fabre, Recordati, Sun Pharmaceutical, and Symimetics. J.J.P. and T.L.K. declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}